Words (Excluding Tãtle and Authors- 300) Title- Cost-Effectiveness Analysis of Nivolumab for the Treatment of Second-Line Advanced Squamous Non-Small Cell Lung Cancer (Nsclc) in Spain
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.2210
https://www.valueinhealthjournal.com/article/S1098-3015(16)33576-8/fulltext
Title :
Words (Excluding Tãtle and Authors- 300) Title- Cost-Effectiveness Analysis of Nivolumab for the Treatment of Second-Line Advanced Squamous Non-Small Cell Lung Cancer (Nsclc) in Spain
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33576-8&doi=10.1016/j.jval.2016.09.2210
First page :
A732
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2094